One caller during Monday's "Lightning Round" segment of Mad Money asked Jim Cramer about Bionano Genomics (BNGO) : "Buy this one for speculation and only for speculation," said Crarmer about the company that provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. Heady stuff.
More from Investing
These names provide shareholders with potential growth in addition to their dividends.
As we say to goodbye to a rough September, let's look what what's weighing on investor sentiment now.
Shares of the consulting company have turned lower from early September.
The identity security management firm gets a quantitative upgrade.